A sub-analysis by KEGG signalling pathways revealed that SLC16A7 co-expressed genes are grouped in pathways associated with PCa, colorectal cancer, renal cell carcinoma, leukemia, melanoma, glioma and mTOR signalling pathway among others (Figure 3B). This evidence concerns the gene MTOR and renal cell carcinoma.